Mohammad Athar Selected Research

Cyclins

9/2012	Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway.
6/2009	Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.
3/2008	Cyclooxygenase-2 inhibitor nimesulide blocks ultraviolet B-induced photocarcinogenesis in SKH-1 hairless mice.
1/2002	Stage-specific alterations of cyclin expression during UVB-induced murine skin tumor development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammad Athar Research Topics

Disease

101	Neoplasms (Cancer) 02/2023 - 01/2002
27	Carcinogenesis 01/2017 - 06/2002
26	Inflammation (Inflammations) 11/2023 - 11/2003
18	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2002
16	Skin Neoplasms (Skin Cancer) 01/2022 - 07/2002
12	Body Weight (Weight, Body) 08/2013 - 10/2003
11	Carcinoma (Carcinomatosis) 01/2022 - 06/2002
11	Melanoma (Melanoma, Malignant) 01/2022 - 10/2005
9	Basal Cell Carcinoma (Rodent Ulcer) 01/2018 - 03/2004
8	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2023 - 01/2014
7	Residual Neoplasm 01/2022 - 08/2012
7	Glioma (Gliomas) 01/2021 - 08/2010
7	Papilloma (Papillomatosis) 01/2011 - 01/2002
6	COVID-19 02/2023 - 01/2020
6	Edema (Dropsy) 01/2023 - 11/2003
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 07/2007
5	Fibrosis (Cirrhosis) 01/2021 - 01/2017
5	Hyperplasia 01/2015 - 03/2004
4	Rhabdomyosarcoma 01/2022 - 08/2010
4	Basal Cell Nevus Syndrome (Gorlin Syndrome) 01/2018 - 03/2004
3	Disease Progression 12/2023 - 01/2022
3	Acute Lung Injury 11/2023 - 11/2018
3	Wounds and Injuries (Trauma) 11/2023 - 05/2011
3	Pain (Aches) 11/2023 - 09/2022
3	Acute Kidney Injury (Acute Renal Failure) 09/2023 - 01/2018
3	Infections 01/2023 - 01/2007
3	Lung Injury 11/2020 - 11/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 09/2008 - 02/2006
2	Chemical Burns (Chemical Burn) 11/2023 - 01/2021
2	Erythema 11/2023 - 03/2004
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2023 - 11/2019
2	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2023 - 07/2021
2	Dysplastic Nevus Syndrome (Dysplastic Nevus) 01/2022 - 01/2021
2	Emphysema 01/2022 - 11/2018

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2004
15	AntioxidantsIBA 01/2015 - 06/2002
13	CytokinesIBA 12/2023 - 02/2006
12	EnzymesIBA 09/2023 - 07/2002
9	lewisiteIBA 11/2023 - 10/2016
9	Cadherins (E-Cadherin)IBA 01/2017 - 12/2008
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2007
8	VimentinIBA 01/2021 - 07/2011
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2004
7	ArsenicIBA 10/2016 - 04/2005
6	Irritants (Vesicants)IBA 11/2023 - 11/2020
6	Arsenicals (Arsenic Compounds)IBA 11/2023 - 10/2016
6	Transcription Factors (Transcription Factor)IBA 01/2021 - 06/2009
6	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 08/2014 - 03/2003
6	Phosphotransferases (Kinase)IBA 08/2012 - 02/2006
6	ferric nitrilotriacetateIBA 10/2010 - 07/2006
5	Cyclin D1IBA 01/2022 - 01/2002
5	LDL Receptors (LDL Receptor)IBA 01/2022 - 01/2014
5	Sirolimus (Rapamycin)FDA Link 02/2019 - 05/2011
5	fisetinIBA 01/2016 - 07/2013
5	Fibronectins (Fibronectin)IBA 01/2016 - 07/2011
5	Caspase 3 (Caspase-3)IBA 01/2013 - 03/2003
5	CarcinogensIBA 01/2012 - 06/2002
5	ResveratrolIBA 05/2011 - 07/2006
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2009 - 07/2002
5	IronIBA 09/2007 - 09/2002
4	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2022 - 08/2010
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 01/2010
4	Vitamin D FDA LinkGeneric 01/2022 - 01/2020
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 06/2009
4	CateninsIBA 05/2020 - 07/2013
4	LigandsIBA 11/2019 - 08/2010
4	anthraceneIBA 05/2016 - 01/2003
4	PolyphenolsIBA 01/2015 - 11/2002
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2014 - 03/2010
4	CyclinsIBA 09/2012 - 01/2002
4	Messenger RNA (mRNA)IBA 09/2008 - 10/2005
4	Free RadicalsIBA 09/2007 - 06/2002
4	TeaIBA 01/2005 - 07/2002
4	Benzoyl Peroxide FDA LinkGeneric 05/2004 - 09/2002
3	Chemical Warfare AgentsIBA 11/2023 - 10/2016
3	CollagenIBA 01/2023 - 01/2014
3	VaccinesIBA 01/2023 - 03/2015
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 07/2011
3	CadmiumIBA 01/2022 - 01/2017
3	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2013
3	Protons (Proton)IBA 09/2021 - 01/2019
3	Retinaldehyde (Retinal)IBA 01/2021 - 01/2021
3	oxidized low density lipoproteinIBA 11/2019 - 07/2015
3	HhAntag691IBA 12/2017 - 09/2014
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016 - 01/2014
3	AcetoneIBA 08/2013 - 03/2004
3	Drinking WaterIBA 12/2011 - 01/2005
3	Glutathione (Reduced Glutathione)IBA 01/2009 - 06/2006
3	InterleukinsIBA 09/2008 - 02/2006
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2008 - 07/2002
2	ChemokinesIBA 12/2023 - 12/2011
2	CholesterolIBA 07/2023 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 06/2023 - 03/2023
2	IgYIBA 06/2023 - 03/2023
2	SteroidsIBA 03/2023 - 07/2021
2	Peptides (Polypeptides)IBA 01/2022 - 03/2004
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2022 - 05/2020

Therapy/Procedure

22	Therapeutics 11/2023 - 02/2006
11	Chemoprevention 11/2022 - 03/2004
4	Oral Administration 01/2011 - 02/2004